Strength
30 mg/1
Manufacturer
AvPAKNDC
50268078013
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TEMAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA071457On Market Since
10/19/2023
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 30 MG CAPSULE has been published 120 times since Mar 13, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0922 per EA |
|---|---|
| All-time high | $0.0965 (Oct 16, 2024) |
| All-time low | $0.0726 (Nov 20, 2024) |
| 52-week high | $0.0946 |
| 52-week low | $0.0894 |
| Median price | $0.0910 |
| Average price | $0.0881 |
| Largest weekly change | -20.4% (Nov 20, 2024) |
| Weeks tracked | 120 |
| Tracking since | Mar 13, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMAZEPAM 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 30 MG CAPSULE, manufactured by AvPAK, is $0.0922 per EA (NDC 50268078013), effective Jun 24, 2026.
How has the price of TEMAZEPAM 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 30 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 120 weekly CMS publications since Mar 13, 2024.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 30 MG CAPSULE?
Since Mar 13, 2024, the NADAC for TEMAZEPAM 30 MG CAPSULE has ranged from a low of $0.0726 (Nov 20, 2024) to a high of $0.0965 (Oct 16, 2024), with a median of $0.0910 per EA.
Are there cheaper alternatives to TEMAZEPAM 30 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as TEMAZEPAM 30 MG CAPSULE, but none are currently priced below it.
Who manufactures TEMAZEPAM 30 MG CAPSULE?
TEMAZEPAM 30 MG CAPSULE (NDC 50268078013) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification